KBIO .. FORM 4 .. 10% OWNER SHKRELI MARTIN .. P 500,169 A $ 0.61 P 97,269 A $ 1.43 P 606,677 A $ 1.93 P 7,000 A $ 2.43 Turing Pharma CEO bought 1.2 mil shares 11/16 & 11/17
Guarantee it, loaded up here, going to get nuts
Company has $1.80 in cash per share. If the KBIO crowd jumps on this it can easily see $3, bet the CEO from MCUR puts out a PR tomorrow connecting them to KBIO in some way, literally
They could liquidate some assets, take care of Blackstone, and be fine, most likely another party will take Blackstones place, Blackstone is greedy, they would make more by working with SUNE, unlike the short said on CNBC
Don't like holding over the weekend when it's up so much, stress
Reeling 8% this morning from a nasty competitor downgrade after yesterday's 37% pop, Needham & Company views recent steps by SunEdison (NYSE: SUNE) as positive to improve the operating structure and address liquidity concerns.
"We see the management shake-up at the board level and the yieldcos, the drop down of higher yield projects to GLBL [N/R], and SUNE's pay down of the margin loan as positive signs that SUNE is responding to investor concerns regarding its liquidity and cash flow generation," Y. Edwin Mok commented. "The stock has rebounded 46% since last Friday's close, which we believe was largely due to short covering. As SUNE continues to improve the operation structure, we see potential for shares to move higher given the depressed levels."
The firm reiterating a Buy rating and price target of $10 on SUNE.
Got in early
Traders slowly finding it
Increasing volume, they are going to run this today, mark my words